Answers are grounded in this paper and cite their sources.
After a brief survey of the factors of clinical tumor radioresistance the available data on the growth rate and on the kinetics of cell proliferation of U.R.D.T. tumors are reviewed. The growth fraction and the cell turnover rate appear to be similar in U.R.D.T. tumors and in other squamous cell carcinomas. These two parameters are correlated with clinical tumor radiosensitivity and chemosensitivity. The possible value of tailoring fractionation and drug administration to the biological characteristics of the tumor is discussed.
No takes yet. Share an insight, caveat, or question.
Tubiana et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: